Register

SmallMolecules.com > Supplier: caymanchemical

Cayman Chemical

Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Company Website

Product Listing

UBP 310 5 mg | ≥98%

Cayman Chemical

A selective antagonist of GluR5

More Information Supplier Page

UBP 310 1 mg | ≥98%

Cayman Chemical

A selective antagonist of GluR5

More Information Supplier Page

UC2288 50 mg | ≥98%

Cayman Chemical

A p21WAF1 inhibitor

More Information Supplier Page

UC2288 25 mg | ≥98%

Cayman Chemical

A p21WAF1 inhibitor

More Information Supplier Page

UC2288 10 mg | ≥98%

Cayman Chemical

A p21WAF1 inhibitor

More Information Supplier Page

UC2288 5 mg | ≥98%

Cayman Chemical

A p21WAF1 inhibitor

More Information Supplier Page

UCB 9260 10 mg | ≥95%

Cayman Chemical

A TNF inhibitor

More Information Supplier Page

UCB 9260 25 mg | ≥95%

Cayman Chemical

A TNF inhibitor

More Information Supplier Page

UCB 9260 5 mg | ≥95%

Cayman Chemical

A TNF inhibitor

More Information Supplier Page

UCB 9260 50 mg | ≥95%

Cayman Chemical

A TNF inhibitor

More Information Supplier Page

UCB 9608 10 mg | ≥98%

Cayman Chemical

A PI4KIIIß inhibitor

More Information Supplier Page

UCB 9608 25 mg | ≥98%

Cayman Chemical

A PI4KIIIß inhibitor

More Information Supplier Page

UCB 9608 5 mg | ≥98%

Cayman Chemical

A PI4KIIIß inhibitor

More Information Supplier Page

UCB 9608 50 mg | ≥98%

Cayman Chemical

A PI4KIIIß inhibitor

More Information Supplier Page

UCF 101 25 mg | ≥98%

Cayman Chemical

An Omi/HtrA2 protease inhibitor

More Information Supplier Page

UCF 101 10 mg | ≥98%

Cayman Chemical

An Omi/HtrA2 protease inhibitor

More Information Supplier Page

UCF 101 5 mg | ≥98%

Cayman Chemical

An Omi/HtrA2 protease inhibitor

More Information Supplier Page

UCF 101 1 mg | ≥98%

Cayman Chemical

An Omi/HtrA2 protease inhibitor

More Information Supplier Page

UCL-TRO-1938 1 mg | ≥98%

Cayman Chemical

An allosteric PI3Ka activator

More Information Supplier Page

UCL-TRO-1938 10 mg | ≥98%

Cayman Chemical

An allosteric PI3Ka activator

More Information Supplier Page

UCL-TRO-1938 5 mg | ≥98%

Cayman Chemical

An allosteric PI3Ka activator

More Information Supplier Page

UCLA gp130 2 10 mg | ≥98%

Cayman Chemical

A humanin peptide mimetic

More Information Supplier Page

UCLA gp130 2 25 mg | ≥98%

Cayman Chemical

A humanin peptide mimetic

More Information Supplier Page

UCLA gp130 2 5 mg | ≥98%

Cayman Chemical

A humanin peptide mimetic

More Information Supplier Page

UCLA gp130 2 50 mg | ≥98%

Cayman Chemical

A humanin peptide mimetic

More Information Supplier Page

UCM-05194 (ammonium salt) 1 mg | ≥95%

Cayman Chemical

An LPA1 agonist

More Information Supplier Page

UCM-05194 (ammonium salt) 5 mg | ≥95%

Cayman Chemical

An LPA1 agonist

More Information Supplier Page

UCM05 10 mg | ≥95%

Cayman Chemical

A fatty acid synthase inhibitor

More Information Supplier Page

UCM05 5 mg | ≥95%

Cayman Chemical

A fatty acid synthase inhibitor

More Information Supplier Page

UCM05 1 mg | ≥95%

Cayman Chemical

A fatty acid synthase inhibitor

More Information Supplier Page

UCM53 10 mg | ≥98%

Cayman Chemical

An inhibitor of bacterial cell division

More Information Supplier Page

UCM53 5 mg | ≥98%

Cayman Chemical

An inhibitor of bacterial cell division

More Information Supplier Page

UCM53 1 mg | ≥98%

Cayman Chemical

An inhibitor of bacterial cell division

More Information Supplier Page

UCM53 500 µg | ≥98%

Cayman Chemical

An inhibitor of bacterial cell division

More Information Supplier Page

UCM707 50 mg | ≥98%

Cayman Chemical

An endocannabinoid analog that potentiates AEA activity

More Information Supplier Page

UCM707 25 mg | ≥98%

Cayman Chemical

An endocannabinoid analog that potentiates AEA activity

More Information Supplier Page

UCM707 10 mg | ≥98%

Cayman Chemical

An endocannabinoid analog that potentiates AEA activity

More Information Supplier Page

UCM707 5 mg | ≥98%

Cayman Chemical

An endocannabinoid analog that potentiates AEA activity

More Information Supplier Page

UCN-01 1 mg | ≥95%

Cayman Chemical

A nonspecific protein kinase inhibitor

More Information Supplier Page

UCN-02 5 mg | ≥95%

Cayman Chemical

A PKC inhibitor

More Information Supplier Page

UCN-02 1 mg | ≥95%

Cayman Chemical

A PKC inhibitor

More Information Supplier Page

UCPH-101 5 mg | ≥98%

Cayman Chemical

A noncompetitive inhibitor of EAAT1

More Information Supplier Page

UCPH-101 1 mg | ≥98%

Cayman Chemical

A noncompetitive inhibitor of EAAT1

More Information Supplier Page

UCPH-101 500 µg | ≥98%

Cayman Chemical

A noncompetitive inhibitor of EAAT1

More Information Supplier Page

UCSF924 1 mg | ≥98%

Cayman Chemical

A dopamine D4 receptor agonist

More Information Supplier Page

UCSF924 10 mg | ≥98%

Cayman Chemical

A dopamine D4 receptor agonist

More Information Supplier Page

UCSF924 25 mg | ≥98%

Cayman Chemical

A dopamine D4 receptor agonist

More Information Supplier Page

UCSF924 5 mg | ≥98%

Cayman Chemical

A dopamine D4 receptor agonist

More Information Supplier Page

Udenafil 50 mg | ≥95%

Cayman Chemical

A PDE5 inhibitor

More Information Supplier Page

Udenafil 25 mg | ≥95%

Cayman Chemical

A PDE5 inhibitor

More Information Supplier Page